Showing results (261-270 of 362) with videos related to
Sort By:
Pageof 37
Zeitschrift Fur Krebsforschung Und Klinische Onkologie. Cancer Research and Clinical Oncology|January 1, 1975
[The primary extranodal manifestation of lympho- and reticulosarcoma of the stomach]H E Reis, S Passek, U Bruntsch, et al.Strahlentherapie|January 1, 1985
[Effect of antineoplastic agents and ionizing radiation on a human testicular cancer heterograft]R Osieka, M Bamberg, R Pfeiffer, et al.Bone Marrow Transplantation|November 18, 2000
Transplantation of highly purified HLA-identical sibling donor peripheral blood CD34+ cells without prophylactic post-transplant immunosuppression in adult patients with first chronic phase chronic myeloid leukemia: results of a phase II studyD W Beelen, R Peceny, A Elmaagacli, et al.Cancer Chemotherapy and Pharmacology|July 8, 1998
Clinical pharmacokinetics of intravenous treosulfan in patients with advanced solid tumorsR A Hilger, A Harstrick, W Eberhardt, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 1, 1994
Weekly high-dose 5-fluorouracil and folinic acid as salvage treatment in advanced gastric cancerU Vanhoefer, H Wilke, H J Weh, et al.Investigational New Drugs|January 1, 1987
Treatment of chronic myelogenous leukemia with recombinant interferon alfa-2bN Niederle, O Kloke, D May, et al.Journal of Cancer Research and Clinical Oncology|January 1, 1987
Increased cytotoxicity of 1-(2-chloroethyl)-1-nitroso-3(4-methyl)-cyclohexylurea by pretreatment with O6-methylguanine in resistant but not in sensitive human melanoma cellsW Dempke, P Nehls, U Wandl, et al.Bone Marrow Transplantation|July 31, 2001
A comparison of chimerism and minimal residual disease between four different allogeneic transplantation methods in patients with chronic myelogenous leukemia in first chronic phaseA H Elmaagacli, K Runkel, N Steckel, et al.Journal of Cancer Research and Clinical Oncology|January 1, 1996
Modulation of multidrug resistance by BIBW22BS in blasts of de novo or relapsed or persistent acute myeloid leukemia ex vivoJ Schröder, M Esteban, M R Müller, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 30, 1999
Gemcitabine as a single agent in the treatment of relapsed or refractory aggressive non-Hodgkin's lymphomaA Fosså, A Santoro, W Hiddemann, et al.Pageof 37